Sequence information
Variant position: 726 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 1375 The length of the canonical sequence.
Location on the sequence:
QPRATTVHAVRDTELAKLPE
G TLGHIKRRYPQVVTRLIHLL
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human QPRATTVHAVRDTELAKLPEG TLGHIKRRYPQVVTRLIHLL
Mouse QPRATTVHAVRDTELAKLPEG TLGHIKRRYPQVVTRLIHLL
Caenorhabditis elegans RPRRNTVMAVRFSHIVCIPEN LLSFVKIRYPQVGNKLLKLI
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 1375
Patatin-like phospholipase domain-containing protein 6
Topological domain
81 – 1375
Cytoplasmic
Binding site
629 – 749
Literature citations
Neuropathy target esterase impairments cause Oliver-McFarlane and Laurence-Moon syndromes.
Hufnagel R.B.; Arno G.; Hein N.D.; Hersheson J.; Prasad M.; Anderson Y.; Krueger L.A.; Gregory L.C.; Stoetzel C.; Jaworek T.J.; Hull S.; Li A.; Plagnol V.; Willen C.M.; Morgan T.M.; Prows C.A.; Hegde R.S.; Riazuddin S.; Grabowski G.A.; Richardson R.J.; Dieterich K.; Huang T.; Revesz T.; Martinez-Barbera J.P.; Sisk R.A.; Jefferies C.; Houlden H.; Dattani M.T.; Fink J.K.; Dollfus H.; Moore A.T.; Ahmed Z.M.;
J. Med. Genet. 52:85-94(2015)
Cited for: TISSUE SPECIFICITY; INVOLVEMENT IN LNMS; INVOLVEMENT IN OMCS; VARIANT LNMS ARG-726; VARIANTS OMCS GLN-1099; ARG-1129; SER-1176 AND ALA-1215;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.